Medical Innovation Exchange

Pfizer's RSV vaccine wins support of FDA panel despite lingering safety and efficacy questions

https://www.fiercebiotech.com/biotech/while-safety-and-efficacy-questions-linger-fda-expert-panel-endorses-pfizers-rsv-vaccine

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!